These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1098017)

  • 1. [Drug trials. Reform or modification of the current system].
    Lemaire A
    Nouv Presse Med; 1975 May; 4(18):1367-71. PubMed ID: 1098017
    [No Abstract]   [Full Text] [Related]  

  • 2. [The drug commission of German physicians and phase IV screening].
    Ochsenfahrt H
    MMW Munch Med Wochenschr; 1983 Oct; 125(42):929-32. PubMed ID: 6417498
    [No Abstract]   [Full Text] [Related]  

  • 3. [The admission of drugs in the Netherlands].
    ten Ham M
    Ned Tijdschr Geneeskd; 1983 May; 127(22):968-71. PubMed ID: 6866153
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences in approving drugs].
    Schnieders B
    Internist (Berl); 1980 Jun; 21(6):325-32. PubMed ID: 7005169
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-use evaluation of thrombolytic agents: a challenge to pharmacists.
    Green JA
    Am J Hosp Pharm; 1988 Oct; 45(10):2192-4. PubMed ID: 3228086
    [No Abstract]   [Full Text] [Related]  

  • 6. [Essential drugs. Current coordination work from the World Health Organisation].
    Lunde PK
    Tidsskr Nor Laegeforen; 1977 Feb; 97(5):225-6. PubMed ID: 841553
    [No Abstract]   [Full Text] [Related]  

  • 7. [Medical experts groups and choice of medications. A fair prioritization process guarantees the reliability of the choice of medications].
    Garpenby P
    Lakartidningen; 2004 Aug; 101(32-33):2480-2, 2484. PubMed ID: 15346621
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical therapeutic trials].
    Mathé G
    Bull Cancer; 1974; 61(2):191-212. PubMed ID: 4619025
    [No Abstract]   [Full Text] [Related]  

  • 9. [Steering committees in drug trials].
    Kleinsorge H
    Med Monatsschr Pharm; 1997 Feb; 20(2):29. PubMed ID: 9132534
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving pharmacy and therapeutics committee operations.
    Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE
    Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality control of drug prescriptions by positive lists--the European Formulary.
    Glaeske G
    Int J Clin Pharmacol Ther; 1994 Aug; 32(8):403-8. PubMed ID: 7981924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No relaxation on drug safety and efficacy.
    Russell AS; Grace M
    World Health Forum; 1993; 14(1):31-3. PubMed ID: 8439367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. $50 M for drug comparisons could produce valuable results.
    Carroll J
    Manag Care; 2004 Apr; 13(4):9-10. PubMed ID: 15146713
    [No Abstract]   [Full Text] [Related]  

  • 14. [Problems in drug registration procedures and their significance for the physician (author's transl)].
    Preisig R
    Ther Umsch; 1974 Nov; 31(11):859-64. PubMed ID: 4428449
    [No Abstract]   [Full Text] [Related]  

  • 15. [Monitoring of clinical trials and interim analysis. 1. Monitoring committee].
    Boutitie F; Bellissant E; Blanchard J; Boissel JP; Cauquil J; Chauvin F; Derzko G; Ducruet T; Durrleman S; Girre JP
    Therapie; 1992; 47(4):345-9. PubMed ID: 1494799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Towards a new drug management].
    Hoffmann M; Ahlner J
    Lakartidningen; 1995 Oct; 92(41):3804, 3807. PubMed ID: 7564634
    [No Abstract]   [Full Text] [Related]  

  • 17. [Controlled clinical trials].
    Jensen AO
    Ugeskr Laeger; 1976 Aug; 138(36):2168-9. PubMed ID: 788269
    [No Abstract]   [Full Text] [Related]  

  • 18. [Modification of the prescribing practice of the physician by drug approval decisions of federal agencies].
    Wartensleben H
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):604-6. PubMed ID: 9527450
    [No Abstract]   [Full Text] [Related]  

  • 19. How to develop a proactive formulary system.
    Crane VS; Gonzalez ER; Hull BL
    Hosp Formul; 1994 Oct; 29(10):700-2, 704-8, 710. PubMed ID: 10137847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The investigational drug steering committee.
    Ratain MJ
    Clin Adv Hematol Oncol; 2007 Oct; 5(10):779-80. PubMed ID: 17998895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.